- Tytuł:
- Ustekinumab reduces serum protein levels associated with cardiovascular risk in psoriasis vulgaris.
- Autorzy:
- Źródło:
- Experimental dermatology [Exp Dermatol] 2022 Sep; Vol. 31 (9), pp. 1341-1351. Date of Electronic Publication: 2022 May 16.
- Typ publikacji:
- Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
- MeSH Terms:
-
Cardiovascular Diseases*/etiology
Psoriasis*/complications
Psoriasis*/drug therapy
Psoriasis*/pathology
Biomarkers ; Heart Disease Risk Factors ; Humans ; Interleukin-6 ; Risk Factors ; Severity of Illness Index ; Ustekinumab/therapeutic use
Czasopismo naukowe